237 related articles for article (PubMed ID: 33503331)
1. Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function.
Fohner AE; Dalton R; Skagen K; Jackson K; Claw KG; Hopkins SE; Robinson R; Khan BA; Prasad B; Schuetz EG; Nickerson DA; Thornton TA; Dillard DA; Boyer BB; Thummel KE; Woodahl EL
Clin Transl Sci; 2021 Jul; 14(4):1292-1302. PubMed ID: 33503331
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.
Fohner A; Muzquiz LI; Austin MA; Gaedigk A; Gordon A; Thornton T; Rieder MJ; Pershouse MA; Putnam EA; Howlett K; Beatty P; Thummel KE; Woodahl EL
Pharmacogenet Genomics; 2013 Aug; 23(8):403-14. PubMed ID: 23778323
[TBL] [Abstract][Full Text] [Related]
3. Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX.
Fohner AE; Robinson R; Yracheta J; Dillard DA; Schilling B; Khan B; Hopkins S; Boyer B; Black J; Wiener H; Tiwari HK; Gordon A; Nickerson D; Tsai JM; Farin FM; Thornton TA; Rettie AE; Thummel KE
Pharmacogenet Genomics; 2015 Jul; 25(7):343-353. PubMed ID: 25946405
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 Genetic Variation Associated with Tamoxifen Biotransformation in American Indian and Alaska Native People.
Khan BA; Robinson R; Fohner AE; Muzquiz LI; Schilling BD; Beans JA; Olnes MJ; Trawicki L; Frydenlund H; Laukes C; Beatty P; Phillips B; Nickerson D; Howlett K; Dillard DA; Thornton TA; Thummel KE; Woodahl EL
Clin Transl Sci; 2018 May; 11(3):312-321. PubMed ID: 29436156
[TBL] [Abstract][Full Text] [Related]
5. Genetic contribution to variable human CYP3A-mediated metabolism.
Lamba JK; Lin YS; Schuetz EG; Thummel KE
Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Functional Effects of
Henderson LM; Hopkins SE; Boyer BB; Thornton TA; Rettie AE; Thummel KE
Drug Metab Dispos; 2021 May; 49(5):345-352. PubMed ID: 33632714
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations.
Claw KG; Beans JA; Lee SB; Avey JP; Stapleton PA; Scherer SE; El-Boraie A; Tyndale RF; Nickerson DA; Dillard DA; Thummel KE; Robinson RF
Nicotine Tob Res; 2020 May; 22(6):910-918. PubMed ID: 31241144
[TBL] [Abstract][Full Text] [Related]
8. CYP3A4*1G and CYP3A5*3 genetic polymorphisms alter the antihypertensive efficacy of amlodipine in patients with hypertension following renal transplantation
.
Huang Y; Wen G; Lu Y; Wen J; Ji Y; Xing X; Li Y; Wen J; Yuan H
Int J Clin Pharmacol Ther; 2017 Feb; 55(2):109-118. PubMed ID: 27841150
[TBL] [Abstract][Full Text] [Related]
9. Association of CYP3A4*1G and CYP3A5*3 With the 1-year Outcome of Acute Ischemic Stroke in the Han Chinese Population.
Li S; Shi CH; Liu XJ; Li YS; Li SH; Song B; Xu YM
J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1860-1865. PubMed ID: 31064695
[TBL] [Abstract][Full Text] [Related]
10. Influence of cytochrome P450 (CYP) 3A4*1G polymorphism on the pharmacokinetics of tacrolimus, probability of acute cellular rejection, and mRNA expression level of CYP3A5 rather than CYP3A4 in living-donor liver transplant patients.
Uesugi M; Hosokawa M; Shinke H; Hashimoto E; Takahashi T; Kawai T; Matsubara K; Ogawa K; Fujimoto Y; Okamoto S; Kaido T; Uemoto S; Masuda S
Biol Pharm Bull; 2013; 36(11):1814-21. PubMed ID: 24189425
[TBL] [Abstract][Full Text] [Related]
11. Regulation of CYP3A4 and CYP3A5 by a lncRNA: a potential underlying mechanism explaining the association between CYP3A4*1G and CYP3A metabolism.
Collins JM; Wang D
Pharmacogenet Genomics; 2022 Jan; 32(1):16-23. PubMed ID: 34320606
[TBL] [Abstract][Full Text] [Related]
12. CYP3A4 and CYP3A5 genotyping by Pyrosequencing.
Garsa AA; McLeod HL; Marsh S
BMC Med Genet; 2005 May; 6():19. PubMed ID: 15882469
[TBL] [Abstract][Full Text] [Related]
13. Genetics, Diet, and Season Are Associated with Serum 25-Hydroxycholecalciferol Concentration in a Yup'ik Study Population from Southwestern Alaska.
Fohner AE; Wang Z; Yracheta J; O'Brien DM; Hopkins SE; Black J; Philip J; Wiener HW; Tiwari HK; Stapleton PL; Tsai JM; Thornton TA; Boyer BB; Thummel KE
J Nutr; 2016 Feb; 146(2):318-25. PubMed ID: 26661839
[TBL] [Abstract][Full Text] [Related]
14. Influence of CYP3A5*3 polymorphism and interaction between CYP3A5*3 and CYP3A4*1G polymorphisms on post-operative fentanyl analgesia in Chinese patients undergoing gynaecological surgery.
Zhang W; Yuan JJ; Kan QC; Zhang LR; Chang YZ; Wang ZY; Li ZS
Eur J Anaesthesiol; 2011 Apr; 28(4):245-50. PubMed ID: 21513075
[TBL] [Abstract][Full Text] [Related]
15. CYP3A4 * 1G Genetic Polymorphism Influences Metabolism of Fentanyl in Human Liver Microsomes in Chinese Patients.
Yuan JJ; Hou JK; Zhang W; Chang YZ; Li ZS; Wang ZY; Du YY; Ma XJ; Zhang LR; Kan QC; Candiotti KA
Pharmacology; 2015; 96(1-2):55-60. PubMed ID: 26088794
[TBL] [Abstract][Full Text] [Related]
16. Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients.
Lepper ER; Baker SD; Permenter M; Ries N; van Schaik RH; Schenk PW; Price DK; Ahn D; Smith NF; Cusatis G; Ingersoll RG; Bates SE; Mathijssen RH; Verweij J; Figg WD; Sparreboom A
Clin Cancer Res; 2005 Oct; 11(20):7398-404. PubMed ID: 16243813
[TBL] [Abstract][Full Text] [Related]
17. Association Between CYP3A4 and CYP3A5 Genotypes and Cyclosporine's Blood Levels and Doses among Jordanian Kidney Transplanted Patients.
El-Shair S; Al Shhab M; Zayed K; Alsmady M; Zihlif M
Curr Drug Metab; 2019; 20(8):682-694. PubMed ID: 31385766
[TBL] [Abstract][Full Text] [Related]
18. The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose.
Dally H; Edler L; Jäger B; Schmezer P; Spiegelhalder B; Dienemann H; Drings P; Schulz V; Kayser K; Bartsch H; Risch A
Pharmacogenetics; 2003 Oct; 13(10):607-18. PubMed ID: 14515059
[TBL] [Abstract][Full Text] [Related]
19. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.
Zuo XC; Ng CM; Barrett JS; Luo AJ; Zhang BK; Deng CH; Xi LY; Cheng K; Ming YZ; Yang GP; Pei Q; Zhu LJ; Yuan H; Liao HQ; Ding JJ; Wu D; Zhou YN; Jing NN; Huang ZJ
Pharmacogenet Genomics; 2013 May; 23(5):251-61. PubMed ID: 23459029
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic determinants of human liver microsomal alfentanil metabolism and the role of cytochrome P450 3A5.
Klees TM; Sheffels P; Thummel KE; Kharasch ED
Anesthesiology; 2005 Mar; 102(3):550-6. PubMed ID: 15731592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]